Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin H Ellis

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|October 22, 2011
Prolonged Blood Storage Does Not Effect Survival in an Animal Model of Hemorrhagic ShockUri Abadi, Gabriel Butenero, Tania Kogan, et al.
Thrombosis Research|July 30, 2018
Appropriateness of non-vitamin K antagonist oral anticoagulant dose in patients with atrial fibrillation in Israel: A population-based studyMartin H Ellis, Sari Greenberg Dotan, Ariel Hammerman, et al.
Experimental Hematology|March 3, 2012
Alteration of lipids and the transcription of lipid-related genes in myelodysplastic syndromes via a TP53-related pathwayMartin H Ellis, Lior Baraf, Aviv Shaish, et al.
Arthritis Care & Research|May 31, 2021
Ethnicity and Antiphospholipid Syndrome in IsraelStanley Niznik, Micha J Rapoport, Orly Avnery, et al.
The American Journal of Medicine|October 3, 2024
Vitamin K Antagonist Anticoagulation in Antiphospholipid Syndrome: Time in Therapeutic Range and Clinical OutcomesKeren Meir, Stanley Niznik, Orly Avnery, et al.
Leukemia & Lymphoma|June 7, 2019
Prevalence and clinical significance of hypercalcemia at diagnosis in diffuse large B-cell lymphomaUri Abadi, Lee Peled, Ronit Gurion, et al.
The American Journal of Medicine|February 19, 2019
Effectiveness and Safety of Off-Label Dose-Reduced Direct Oral Anticoagulants in Atrial FibrillationRonen Arbel, Ruslan Sergienko, Ariel Hammerman, et al.
Annals of Hematology|October 14, 2016
Management of extreme thrombocytosis in myeloproliferative neoplasms: an international physician surveyMaya Koren-Michowitz, Noa Lavi, Martin H Ellis, et al.
Leukemia Research|August 27, 2017
Ruxolitinib for the management of myelofibrosis: Results of an international physician surveyMartin H Ellis, Maya Koren-Michowitz, Noa Lavi, et al.
Rheumatology (Oxford, England)|August 12, 2023
Heart valve disease in primary antiphospholipid syndromeStanley Niznik, Micha J Rapoport, Orly Avnery, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|October 22, 2011
Prolonged Blood Storage Does Not Effect Survival in an Animal Model of Hemorrhagic ShockUri Abadi, Gabriel Butenero, Tania Kogan, et al.
Thrombosis Research|July 30, 2018
Appropriateness of non-vitamin K antagonist oral anticoagulant dose in patients with atrial fibrillation in Israel: A population-based studyMartin H Ellis, Sari Greenberg Dotan, Ariel Hammerman, et al.
Experimental Hematology|March 3, 2012
Alteration of lipids and the transcription of lipid-related genes in myelodysplastic syndromes via a TP53-related pathwayMartin H Ellis, Lior Baraf, Aviv Shaish, et al.
Arthritis Care & Research|May 31, 2021
Ethnicity and Antiphospholipid Syndrome in IsraelStanley Niznik, Micha J Rapoport, Orly Avnery, et al.
The American Journal of Medicine|October 3, 2024
Vitamin K Antagonist Anticoagulation in Antiphospholipid Syndrome: Time in Therapeutic Range and Clinical OutcomesKeren Meir, Stanley Niznik, Orly Avnery, et al.
Leukemia & Lymphoma|June 7, 2019
Prevalence and clinical significance of hypercalcemia at diagnosis in diffuse large B-cell lymphomaUri Abadi, Lee Peled, Ronit Gurion, et al.
The American Journal of Medicine|February 19, 2019
Effectiveness and Safety of Off-Label Dose-Reduced Direct Oral Anticoagulants in Atrial FibrillationRonen Arbel, Ruslan Sergienko, Ariel Hammerman, et al.
Annals of Hematology|October 14, 2016
Management of extreme thrombocytosis in myeloproliferative neoplasms: an international physician surveyMaya Koren-Michowitz, Noa Lavi, Martin H Ellis, et al.
Leukemia Research|August 27, 2017
Ruxolitinib for the management of myelofibrosis: Results of an international physician surveyMartin H Ellis, Maya Koren-Michowitz, Noa Lavi, et al.
Rheumatology (Oxford, England)|August 12, 2023
Heart valve disease in primary antiphospholipid syndromeStanley Niznik, Micha J Rapoport, Orly Avnery, et al.
Pageof 6